Patients’ high acceptability of a future therapeutic HIV vaccine in France: a French paradox? - Aix-Marseille Université Access content directly
Journal Articles BMC Infectious Diseases Year : 2019

Patients’ high acceptability of a future therapeutic HIV vaccine in France: a French paradox?

Abstract

Background France is the European country with the lowest level of confidence in vaccines. Measurement of patients’ acceptability towards a future therapeutic HIV vaccine is critically important. Thus, the aim of this study was to evaluate patients’ acceptability of a future therapeutic HIV vaccine in a representative cohort of French patients living with HIV-AIDS (PLWHs). Methods This multicentre study used quantitative and qualitative methods to assess PLWHs’ opinions and their potential acceptance of a future therapeutic HIV vaccine. Cross-sectional study on 220 HIV-1 infected outpatients, aged 18–75 years. Results The participants’ characteristics were similar to those of the overall French PLWH population. Responses from the questionnaires showed high indices of acceptance: the mean score for acceptability on the Visual Analog Scale VAS was 8.4 of 10, and 92% of patients agreed to be vaccinated if a therapeutic vaccine became available. Acceptability depended on the expected characteristics of the vaccine, notably the duration of its effectiveness: 44% of participants expected it to be effective for life. This acceptance was not associated with socio-demographic, clinical (mode of contamination, duration of disease), quality of life, or illness-perception parameters. Acceptability was also strongly correlated with confidence in the treating physician. Conclusion The PLWHs within our cohort had high indices of acceptance to a future therapeutic HIV vaccine.
Fichier principal
Vignette du fichier
s12879-019-4056-6.pdf (815.75 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

hal-02263740 , version 1 (22-05-2020)

Licence

Attribution

Identifiers

Cite

Svetlane Dimi, David Zucman, Olivier Chassany, Christophe Lalanne, Thierry Prazuck, et al.. Patients’ high acceptability of a future therapeutic HIV vaccine in France: a French paradox?. BMC Infectious Diseases, 2019, 19 (1), ⟨10.1186/s12879-019-4056-6⟩. ⟨hal-02263740⟩
119 View
55 Download

Altmetric

Share

Gmail Facebook X LinkedIn More